1. Home
  2. PBYI vs AVD Comparison

PBYI vs AVD Comparison

Compare PBYI & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • AVD
  • Stock Information
  • Founded
  • PBYI 2010
  • AVD 1969
  • Country
  • PBYI United States
  • AVD United States
  • Employees
  • PBYI N/A
  • AVD N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • AVD Agricultural Chemicals
  • Sector
  • PBYI Health Care
  • AVD Industrials
  • Exchange
  • PBYI Nasdaq
  • AVD Nasdaq
  • Market Cap
  • PBYI 138.4M
  • AVD 135.6M
  • IPO Year
  • PBYI N/A
  • AVD N/A
  • Fundamental
  • Price
  • PBYI $2.91
  • AVD $4.46
  • Analyst Decision
  • PBYI Strong Buy
  • AVD Strong Buy
  • Analyst Count
  • PBYI 1
  • AVD 1
  • Target Price
  • PBYI $7.00
  • AVD $14.00
  • AVG Volume (30 Days)
  • PBYI 280.0K
  • AVD 134.0K
  • Earning Date
  • PBYI 05-08-2025
  • AVD 05-20-2025
  • Dividend Yield
  • PBYI N/A
  • AVD 0.68%
  • EPS Growth
  • PBYI 143.51
  • AVD N/A
  • EPS
  • PBYI 0.77
  • AVD N/A
  • Revenue
  • PBYI $232,668,000.00
  • AVD $553,839,000.00
  • Revenue This Year
  • PBYI N/A
  • AVD N/A
  • Revenue Next Year
  • PBYI N/A
  • AVD $4.35
  • P/E Ratio
  • PBYI $3.78
  • AVD N/A
  • Revenue Growth
  • PBYI 2.67
  • AVD N/A
  • 52 Week Low
  • PBYI $2.23
  • AVD $3.28
  • 52 Week High
  • PBYI $5.20
  • AVD $12.67
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 44.50
  • AVD 58.33
  • Support Level
  • PBYI $2.88
  • AVD $4.10
  • Resistance Level
  • PBYI $3.14
  • AVD $4.33
  • Average True Range (ATR)
  • PBYI 0.16
  • AVD 0.19
  • MACD
  • PBYI 0.00
  • AVD 0.06
  • Stochastic Oscillator
  • PBYI 11.36
  • AVD 91.25

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

Share on Social Networks: